Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025

HAE 01.08.2025

SERA-AI Powered Highlights
Date of Upcoming Event:2025-02-06
Name of Upcoming Event:Q3 2025 Haemonetics Corporation Earnings Conference Call
Full Press ReleaseSEC FilingsOur HAE Tweets

About Gravity Analytica

Recent News

  • 01.15.2025 - 43rd Annual J.P. Morgan Healthcare Conference
  • 01.14.2025 - Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A
  • 01.08.2025 - Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025

Recent Filings

  • 01.14.2025 - EX-99.1 EX-99.1
  • 01.14.2025 - 8-K Current report
  • 11.14.2024 - SC 13G Statement of Beneficial Ownership by Certain Investors

BOSTON,Jan. 8, 2025/PRNewswire/ --Haemonetics Corporation(NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2025 financial results at6:00 am ETonThursday, February 6, 2025. The Company will hold a conference call with investors and analysts to discuss results and answer questions at8:00 am ETonFebruary 6, 2025.

The call can be accessed via teleconference at:Q3 2025 Haemonetics Corporation Earnings Conference Call.Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.

A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link:https://edge.media-server.com/mmc/p/63jte4ra

A replay of the conference call and webcast will be available for one year beginning onFebruary 6, 2025at11:00 am ETusing the conference call webcast link provided in this press release.

ABOUT HAEMONETICS

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visitwww.haemonetics.com.

Investor Contacts:

Olga Guyette, Vice President-Investor Relations & Treasury

David Trenk, Manager-Investor Relations

(781) 356-9763

(203) 733-4987

olga.guyette@haemonetics.com

david.trenk@haemonetics.com

Media Contact:

Josh Gitelson, Sr. Director-Global Communications

(781) 356-9776

josh.gitelson@haemonetics.com

CisionView original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-third-quarter-fiscal-year-2025-results-february-6-2025-302346400.html

SOURCEHaemonetics Corporation

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com